Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2023

Open Access 01-12-2023 | Irritable Bowel Syndrome | Study protocol

The effect of eye movement desensitization and reprocessing (EMDR) on abdominal pain in patients with irritable bowel syndrome (IBS): a study protocol for a randomized controlled trial (EMDR4IBS)

Authors: B. Wertheim, E. E. Aarts, C. de Roos, Y. R. van Rood

Published in: Trials | Issue 1/2023

Login to get access

Abstract

Background

Irritable bowel syndrome (IBS) is a highly prevalent disorder for which treatment options such as medication, diets, and hypnotherapy either have shown limited effect or relieve symptoms in only a limited subset of patients. Abdominal pain is the key criterion for the diagnosis and is deemed the most distressing IBS symptom, and the most disruptive of everyday life. A growing body of research demonstrates the effect of Eye Movement Desensitization and Reprocessing (EMDR) on chronic pain. EMDR is known as a safe and successful treatment for disorders in which unresolved traumatic memories play a role in the cause or maintenance of symptoms. In IBS, activated memories may increase pain through pain flashbacks and the stress generated by unresolved memories. The aim of this study is to ascertain whether applying EMDR to traumatic memories including pain memories will reduce abdominal pain in IBS patients.

Methods

This study is a randomized controlled trial which will be conducted at a city hospital in the Netherlands. Adult patients with considerable IBS pain (pain intensity at least 60/100 during at least 5/10 days) will be randomly assigned to either EMDR therapy or the wait list. We aim to include 34 participants. The EMDR condition comprises seven sessions, around 90 min in length delivered weekly, the first of which is a case conceptualization session. All participants will be assessed at baseline, post-treatment, and at 3 months follow-up. The primary outcome measure is pain intensity on a Likert scale which is self-reported daily during a 2-week period. Secondary outcomes include similar daily ratings on other IBS symptoms and reported hindrance of valued activities, and also standardized questionnaires on IBS symptoms and Quality of Life. Data will be analyzed by a Linear Mixed Effects Model for repeated measures.

Discussion

The results are expected to gain insight into the effectiveness of EMDR treatment on abdominal pain in IBS. As there are very few effective treatment options for IBS-related abdominal pain, this study could have important implications for clinical practice.

Trial registration

Human ethics committee MEC-U NL71740.100.20. International Clinical Trial Registry Platform: NL8894. Prospectively registered on 28 January 2020.
Appendix
Available only for authorised users
Literature
1.
Van de Lisdonk EF VdBW, Lagro-Janssen ALM, Schers HJ. redactie. Ziekten in de huisartspraktijk. Maarssen: Elsevier Gezondheidszorg; 2008.
2.
Creed F, Ratcliffe J, Fernandez L, Tomenson B, Palmer S, Rigby C, et al. Health-related quality of life and health care costs in severe, refractory irritable bowel syndrome. Ann Intern Med. 2001;134(9 Pt 2):860–8.PubMedCrossRef
3.
Canavan C, West J, Card T. Review article: the economic impact of the irritable bowel syndrome. Aliment Pharmacol Ther. 2014;40(9):1023–34.PubMedCrossRef
4.
5.
Cain KC, Headstrom P, Jarrett ME, Motzer SA, Park H, Burr RL, et al. Abdominal pain impacts quality of life in women with irritable bowel syndrome. Official J Am College of Gastroenterol. 2006;101(1):124–32.CrossRef
6.
Heitkemper M, Cain KC, Shulman R, Burr R, Poppe A, Jarrett M. Subtypes of irritable bowel syndrome based on abdominal pain/discomfort severity and bowel pattern. Dig Dis Sci. 2011;56(7):2050–8.PubMedPubMedCentralCrossRef
7.
Miller V, Hopkins L, Whorwell PJ. Suicidal ideation in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2004;2(12):1064–8.PubMedCrossRef
8.
Chen L, Ilham SJ, Feng B. Pharmacological approach for managing pain in irritable bowel syndrome: a review article. Anesth Pain Med. 2017;7(2): e42747.PubMedPubMedCentralCrossRef
9.
Hulisz D. The burden of illness of irritable bowel syndrome: current challenges and hope for the future. J Manag Care Pharm. 2004;10(4):299–309.PubMed
10.
Horst vdH, de Wit NJ, Quartero AO, Muris JWM, Berger MY, Bijkerk CJ, Geijer RMM, Woutersen-Koch H. Directive for Dutch General Practitioners concerning Irritable Bowel Syndrome (NHG Standaard Prikkelbare Darm Syndroom). 2012.
11.
Ford AC, Lacy BE, Harris LA, Quigley EMM, Moayyedi P. Effect of antidepressants and psychological therapies in irritable bowel syndrome: an updated systematic review and meta-analysis. Am J Gastroenterol. 2019;114(1):21–39.PubMedCrossRef
12.
Lackner JM, Mesmer C, Morley S, Dowzer C, Hamilton S. Psychological treatments for irritable bowel syndrome: a systematic review and meta-analysis. J Consult Clin Psychol. 2004;72(6):1100–13.PubMedCrossRef
13.
Palsson OS. Hypnosis treatment of gastrointestinal disorders: a comprehensive review of the empirical evidence. Am J Clin Hypn. 2015;58(2):134–58.PubMedCrossRef
14.
Peters SL, Muir JG, Gibson PR. Review article: gut-directed hypnotherapy in the management of irritable bowel syndrome and inflammatory bowel disease. Aliment Pharmacol Ther. 2015;41(11):1104–15.PubMedCrossRef
15.
Surdea-Blaga T, Baban A, Nedelcu L, Dumitrascu DL. Psychological interventions for irritable bowel syndrome. J Gastrointestin Liver Dis. 2016;25(3):359–66.PubMedCrossRef
16.
Zijdenbos IL, de Wit NJ, van der Heijden GJ, Rubin G, Quartero AO. Psychological treatments for the management of irritable bowel syndrome. Cochrane Database Syst Rev. 2009;21(1):Cd006442.
17.
Bisson JI, Berliner L, Cloitre M, Forbes D, Jensen TK, Lewis C, et al. The international society for traumatic stress studies new guidelines for the prevention and treatment of posttraumatic stress disorder: methodology and development process. J Trauma Stress. 2019;32(4):475–83.PubMedCrossRef
18.
19.
20.
van Rood YR, de Roos C. EMDR in the treatment of medically unexplained symptoms: a systematic review. J EMDR Pract Res. 2009;3(4):248–63.CrossRef
21.
Tefft AJ, Jordan IO. Eye movement desensitization reprocessing as treatment for chronic pain syndromes: a literature review. J Am Psychiatr Nurses Assoc. 2016;22(3):192–214.PubMedCrossRef
22.
Tesarz J, Leisner S, Gerhardt A, Janke S, Seidler GH, Eich W, et al. Effects of eye movement desensitization and reprocessing (EMDR) treatment in chronic pain patients: a systematic review. Pain Med. 2014;15(2):247–63.PubMedCrossRef
23.
Tesarz J, Wicking M, Bernardy K, Seidler GH. EMDR therapy’s efficacy in the treatment of pain. J EMDR Prac Res. 2019;13(4):337–44.CrossRef
24.
Macdonald B, Salomons TV, Meteyard L, Whalley MG. Prevalence of pain flashbacks in posttraumatic stress disorder arising from exposure to multiple traumas or childhood traumatization. Canadian Journal of Pain. 2018;2(1):48–56.PubMedPubMedCentralCrossRef
25.
Salomons TV, Osterman JE, Gagliese L, Katz J. Pain flashbacks in posttraumatic stress disorder. Clin J Pain. 2004;20(2):83–7.PubMedCrossRef
26.
Schreiber S, Galai-Gat T. Uncontrolled pain following physical injury as the core-trauma in post-traumatic stress disorder. Pain. 1993;54(1):107–10.PubMedCrossRef
27.
Whalley MG, Farmer E, Brewin CR. Pain flashbacks following the July 7th 2005 London bombings. Pain. 2007;132(3):332–6.PubMedCrossRef
28.
de Roos C, Veenstra AC, de Jongh A, den Hollander-Gijsman M, van der Wee NJ, Zitman FG, et al. Treatment of chronic phantom limb pain using a trauma-focused psychological approach. Pain Res Manag. 2010;15(2):65–71.PubMedPubMedCentralCrossRef
29.
Elsenbruch S. Abdominal pain in irritable bowel syndrome: a review of putative psychological, neural and neuro-immune mechanisms. Brain Behav Immun. 2011;25(3):386–94.PubMedCrossRef
30.
Mayer EA, Tillisch K. The brain-gut axis in abdominal pain syndromes. Annu Rev Med. 2011;62:381–96.PubMedCrossRef
31.
Shapiro F. The role of eye movement desensitization and reprocessing (EMDR) therapy in medicine: addressing the psychological and physical symptoms stemming from adverse life experiences. Perm J. 2014;18(1):71–7.PubMedPubMedCentralCrossRef
32.
Shapiro F. Eye movement desensitization and reprocessing (EMDR) therapy: Basic principles, protocols, and procedures. New York: Guilford Publications; 2017.
33.
Ten Broeke E, De Jongh A, Hornsveld H. EMDR standard protocol Dutch. 2021.
34.
Lenferink LIM, Meyerbröker K, Boelen PA. PTSD treatment in times of COVID-19: a systematic review of the effects of online EMDR. Psychiatry Res. 2020;293: 113438.PubMedPubMedCentralCrossRef
35.
Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther. 1997;11(2):395–402.PubMedCrossRef
36.
Irvine EJ, Whitehead WE, Chey WD, Matsueda K, Shaw M, Talley NJ, et al. Design of treatment trials for functional gastrointestinal disorders. Gastroenterology. 2006;130(5):1538–51.PubMedCrossRef
37.
Andrae DA, Patrick DL, Drossman DA, Covington PS. Evaluation of the Irritable Bowel Syndrome Quality of Life (IBS-QOL) questionnaire in diarrheal-predominant irritable bowel syndrome patients. Health Qual Life Outcomes. 2013;11:208.PubMedPubMedCentralCrossRef
38.
Patrick DL, Drossman DA, Frederick IO, DiCesare J, Puder KL. Quality of life in persons with irritable bowel syndrome: development and validation of a new measure. Dig Dis Sci. 1998;43(2):400–11.PubMedCrossRef
39.
Camilleri M. Editorial: is adequate relief fatally flawed or adequate as an end point in irritable bowel syndrome? Am J Gastroenterol. 2009;104(4):920–2.PubMedPubMedCentralCrossRef
40.
Mangel A, Hahn B, Heath A, Northcutt A, Kong S, Dukes G, et al. Adequate relief as an endpoint in clinical trials in irritable bowel syndrome. J Int Med Res. 1998;26(2):76–81.PubMedCrossRef
41.
Gray MJ, Litz BT, Hsu JL, Lombardo TW. Psychometric Properties of the Life Events Checklist. Assessment. 2004;11(4):330–41.PubMedCrossRef
42.
Monson CM, Gradus JL, Young-Xu Y, Schnurr PP, Price JL, Schumm JA. Change in posttraumatic stress disorder symptoms: do clinicians and patients agree? Psychol Assess. 2008;20(2):131–8.PubMedCrossRef
43.
Kearney DJ, Kamp KJ, Storms M, Simpson TL. Prevalence of gastrointestinal symptoms and irritable bowel syndrome among individuals with symptomatic posttraumatic stress disorder. J Clin Gastroenterol. 2022;56(7):592–6.
44.
Ng QX, Soh AYS, Loke W, Venkatanarayanan N, Lim DY, Yeo WS. Systematic review with meta-analysis: the association between post-traumatic stress disorder and irritable bowel syndrome. J Gastroenterol Hepatol. 2019;34(1):68–73.PubMedCrossRef
45.
Russell MC. War-related medically unexplained symptoms, prevalence, and treatment: utilizing EMDR within the armed services. J EMDR Pract Res. 2008;2(3):212–25.CrossRef
46.
Weaver TL, Nishith P, Resick PA. Prolonged exposure therapy and irritable bowel syndrome: a case study examining the impact of a trauma-focused treatment on a physical condition. Cogn Behav Pract. 1998;5(1):103–22.PubMedPubMedCentralCrossRef
47.
Bijkerk CJ, de Wit NJ, Muris JW, Jones RH, Knottnerus JA, Hoes AW. Outcome measures in irritable bowel syndrome: comparison of psychometric and methodological characteristics. Am J Gastroenterol. 2003;98(1):122–7.PubMedCrossRef
48.
Whitehead WE. Control groups appropriate for behavioral interventions. Gastroenterology. 2004;126(1 Suppl 1):S159–63.PubMedCrossRef
49.
Flik CE, Bakker L, Laan W, van Rood YR, Smout AJ, de Wit NJ. Systematic review: The placebo effect of psychological interventions in the treatment of irritable bowel syndrome. World J Gastroenterol. 2017;23(12):2223–33.PubMedPubMedCentralCrossRef
50.
Spiller RC. Problems and challenges in the design of irritable bowel syndrome clinical trials: experience from published trials. Am J Med. 1999;107(5A):91S-S97.PubMedCrossRef
51.
Bosman M, Elsenbruch S, Corsetti M, Tack J, Simrén M, Winkens B, et al. The placebo response rate in pharmacological trials in patients with irritable bowel syndrome: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2021;6(6):459–73.PubMedCrossRef
52.
53.
Patel SMS, Legedza W.B., Ock A, Kaptchuk S.M., Conboy T.J., Canenguez L, Park K, Kelly J.K., Jacobson E, Kerr E, Lembo J.C. The placebo effect in irritable bowel syndrome trials: a meta-analysis. Neurogastroenterol Motil  2005;17(3):332–40.PubMedCrossRef
54.
55.
Hanssen DJC, Bos LR, Finch TL, Rosmalen JGM. Barriers and facilitators to implementing interventions for medically unexplained symptoms in primary and secondary care: A systematic review. Gen Hosp Psychiatry. 2021;73:101–13.PubMedCrossRef
56.
Cooper A, Abbass A, Zed J, Bedford L, Sampalli T, Town J. Implementing a psychotherapy service for medically unexplained symptoms in a primary care setting. J Clin Med. 2017;6(12):109.PubMedPubMedCentralCrossRef
Metadata
Title
The effect of eye movement desensitization and reprocessing (EMDR) on abdominal pain in patients with irritable bowel syndrome (IBS): a study protocol for a randomized controlled trial (EMDR4IBS)
Authors
B. Wertheim
E. E. Aarts
C. de Roos
Y. R. van Rood
Publication date
01-12-2023
Publisher
BioMed Central
Published in
Trials / Issue 1/2023
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-023-07784-1

Other articles of this Issue 1/2023

Trials 1/2023 Go to the issue

Study protocol

Can dexamethasone improve postoperative sleep and postoperative delirium in elderly patients undergoing robot-assisted laparoscopic radical prostatectomy? Protocol for a prospective, randomized, double-blind, controlled study

Study protocol

New ways to cope with depression—study protocol for a randomized controlled mixed methods trial of bouldering psychotherapy (BPT) and mental model therapy (MMT)

Correction

Correction: Efect of Tan Tui combined with kinesio taping on the posture control of patients with PFPS: protocol for a randomized controlled trial

Study protocol

A multicentre randomised controlled trial of a guided self-help cognitive behavioural therapy to MANage the impact of hot flushes and night sweats in patients with prostate CANcer undergoing androgen deprivation therapy (MANCAN2)

Study protocol

The effectiveness and cost-effectiveness of a group domestic abuse perpetrator programme: protocol for a randomised controlled trial

Study protocol

Case management and care expertise as a prevention approach for adults with intellectual disabilities (FaPP-MgB): study protocol for a randomized-controlled trial